Rotterdam-based Pan Most cancers T, a biotech startup specialising in superior T cell therapies for stable most cancers remedy, has closed €4.25M in...
In vivo antitumor efficacy researchAll animal procedures have been carried out in accordance with the Directive of The European Parliament on the safety...